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NIDDK Career Transition Award (K22) in
Patient-Oriented Research
The overall aim of the National Institute of Diabetes
and Digestive and Kidney Diseases (NIDDK)
Career Transition Award (K22) is to enable out-
standing physician-scientists to obtain clinical
research training experiences in the NIDDK
Intramural Research Program and to facilitate their
successful transition to an extramural environment
as independent researchers. The award will provide
up to 3 years of support for research training in an
NIDDK intramural clinical laboratory followed by
2 years of support for an independent research pro-
gram at an extramural institution. The combined
duration may not exceed 5 years. It is anticipated
that awardees will subsequently obtain research pro-
ject grants, such as the R01, to support the continu-
ation of their research.
NIDDK Intramural Research Program. The
NIDDK intramural research environment provides
a rich and unique opportunity for the training of
postdoctoral fellows and early career scientists. The
Intramural Research Program at the NIDDK con-
ducts basic biomedical, translational, and clinical
research in the broad areas of diabetes, endocrinol-
ogy, metabolism, transplantation, hepatitis, diges-
tive and kidney diseases, hematopoiesis, and
hemoglobinopathies.
Eligibility for and receipt of this award is
dependent upon participation in the NIDDK
Senior Clinical Research Fellowship Program
(http://fellowshipoffice.niddk.nih.gov/scrfp/). The
3-year program is built on a solid foundation of the
NIH–Duke University Clinical Research Program
that offers didactic courses in research design and
management, statistical analysis, and bioethics.
Enrollment in the NIH–Duke University Program
is required of all participants in the NIDDK Senior
Clinical Research Fellowship Program. There is also
direct, hands-on practical experience in clinical
investigation through an individualized research
project as part of the thesis requirement. The com-
bined course of study ultimately leads to the award-
ing of a Masters Degree in Clinical Research.
Detailed information about programmatic areas
in clinical, translational, and patient-oriented
research as well as potential intramural NIDDK
mentors, clinical protocols, and laboratories may be
obtained at http://fellowshipoffice.niddk.nih.gov/
scrfp/ andhttp://intramural.niddk.nih.gov.
This Program Announcement will use the
National Institutes of Health (NIH) Career
Transition Award (K22) mechanism. Responsibility
for the planning, direction, and execution of the pro-
posed project will reside with the applicant and the
proposed mentor (co-mentor).
The total period of support is a maximum of 5
years (3 years of intramural funding and 2 years of
extramural funding). Awards are not renewable.
Total direct costs for Phase I (intramural) are based
on the candidate’s experience; those for Phase II
(extramural) may not exceed $175,000 per year (for
salary and research support) plus fringe beneﬁts (spe-
ciﬁc allowable costs are described below).
Transition from Phase I (the intramural period
of support) to Phase II (the extramural period) is not
automatic. Approval of the transition will be based
on the success of the awardee’s research program as
determined by yearly scientific review and by the
evaluation of a research and career development plan
to be carried out at the extramural institution.
Additionally, the extramural institution must
demonstrate a commitment to the candidate by
providing a minimum of 75% protected research
time, space, and resources needed to perform the
proposed research project and appropriate scientiﬁc
mentoring. A plan for career development that will
lead to research independence and the ability to suc-
cessfully compete for research support is essential.
Awardees approved to proceed with the second
phase of support will receive notiﬁcation of approval
in writing from the NIDDK. An application from
the extramural institution on behalf of the candidate
will be required for the NIDDK to process the sec-
ond phase of the award (details appear in the section
“Activating the Extramural Support Phase” in the
online announcement).
This funding opportunity uses just-in-time con-
cepts. The PHS 398 application instructions are
available at http://grants.nih.gov/grants/funding/
phs398/phs398.html in an interactive format.
Applicants must use the currently approved version
of the PHS 398. For further assistance contact
GrantsInfo, by phone 301-435-0714 (telecommuni-
cations for the hearing impaired: TTY 301-451-
0088), or by e-mail: GrantsInfo@nih.gov.
Applications must be prepared using the most
current PHS 398 research grant application instruc-
tions and forms. Applications must have a Dun &
Bradstreet Data Universal Numbering System
(DUNS) number as the universal identifier when
applying for federal grants or cooperative agreements.
The D&B number can be obtained by calling 866-
705-5711 or through the web site at http://www.
dnb.com/us/. The D&B number should be entered
on line 11 of the face page of the PHS 398 form. 
The application submission dates for this PAR
are available at http://grants.nih.gov/grants/fund-
ing/submissionschedule.htm. The complete version
of this PAR is available at http://grants.nih.gov/
grants/guide/par-ﬁles/PAR-06-002. 
Contacts: Direct questions about the intramural
phase, including the initial application process and
opportunities for scientiﬁc research within the intra-
mural program to: Louis Simchowitz, Office of
Fellow Recruitment and Career Development,
Division of Intramural Research, National Institute
of Diabetes and Digestive and Kidney Diseases,
Building 12A, Room 3011, 12 South Drive,
Bethesda, MD 20892-5632 USA, 301-451-9808,
fax: 301-402-7461, e-mail: LS347F@nih.gov.
Direct questions about the extramural phase to:
Judith Podskalny, Division of Digestive Diseases and
Nutrition, National Institute of Diabetes and
Digestive and Kidney Diseases, 6707 Democracy
Boulevard, Room 667, Bethesda, MD 20892-5450
USA, 301-594-8876, fax: 301-480-8300, e-mail:
JP52S@nih.gov; Mary Frances Picciano, Office of
Dietary Supplements, National Institutes of Health,
6100 Executive Boulevard, Suite 3B01, Bethesda,
MD 20892-7517 USA, 301-435-3608, fax: 301-
480-1845, e-mail: MP288D@nih.gov. Reference:
PAR-06-002.
Career Development Program in the Genetics
and Genomics of Lung Diseases (K12)
Lung diseases are genetically complex diseases in
which many genes and many environmental factors
interact. Identification of gene variants associated
with such diseases will greatly facilitate the charac-
terization of the contribution that genes and envi-
ronment play in the development of pathological
conditions like asthma and chronic obstructive lung
disease. We recognize that, in the pulmonary com-
munity, genetic and genomic approaches are not
sufficiently well utilized, and this deficiency has
limited pulmonary investigators in taking full
advantage of the tools and information that have
been generated by the human genome project. We
believe that this is due in part to the lack of a criti-
cal mass of junior investigators properly trained and
interested in applying their knowledge to the dis-
eases of the lung.
This new program will utilize the K12 NIH
Institutional Mentored Research Scientist
Development Program to give M.D. and Ph.D.
scientists, who are already committed to the study
of lung diseases and who have completed their
M.D. or Ph.D. degree within the last 5 years,
opportunities to obtain additional career develop-
ment and training in the genetic bases and
genomic analysis of such diseases. They will
accomplish this by being part of interdisciplinary
research groups in which several different genetic
and genomic techniques are being applied to the
study of lung diseases.
We encourage applications that propose, at least
in part, a specific lung disease–related research
theme where each scholar/faculties team would be in
charge of a different aspect of the research, such as
clinical phenotyping, human sample selection, geno-
typing and SNPs analysis, expression proﬁle analysis,
and the selection and application of the right soft-
ware for data analysis. This approach to career devel-
opment would give each scholar an appreciation of
the complexity of the issues surrounding a complex
lung disease and the need for integration and inter-
action of the various components.
K12 Institutional Mentored Research Scientist
development programs are awards to organizations
which include domestic, for-profit and nonprofit,
public and private institutions, such as universities,
colleges, and hospitals to support career development
experiences for new investigators leading to research
independence. Under this award, newly trained
investigators are to be selected and appointed to this
program by the grantee institution.
Individuals who wish to apply as principal
investigators (PIs) should be senior-funded investi-
gators who are well established in their areas of
research and who will recruit and mentor new schol-
ars. The participating institutions will be encouraged
to also develop a formal training curriculum that
includes course and hands-on activities.
The primary goal of this RFA is to promote
comprehensive genetic and genomic research career
development activities, including training for
senior postdoctoral fellows and junior faculty–level
health professionals who want to pursue academic
careers in pulmonary medicine. Through this ini-
tiative, the National Heart, Lung, and Blood
Institute (NHLBI) will support several multidisci-
plinary career development programs to prepare
these individuals for academic research careers in
the genetics and genomics of pulmonary diseases.
The specific research career development
objectives of this RFA, which is focused on the
areas of genetics and genomics of lung diseases are
to: 1) increase national capacity for genetic and
genomic research in the area of lung diseases;
2) increase the number of mentors in this area; and
3) equip new academic researchers with the knowl-
edge and skills necessary to address the genetic
bases of complex lung diseases.
These objectives stem from the fact that,
despite very substantial progress made in the area
of genetics and genomics in the last 10 years, the
lung research community has been lagging behindFellowships, Grants, & Awards
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other organ-focused research communities in the
ability to take advantage of the tools and informa-
tion generated by the human genome project and
other related programs that followed it.
It is important to note that the proposed pro-
grams are distinct from traditional clinical fellow-
ships or career development programs. Programs
funded by this NHLBI initiative require a 1-year
multidisciplinary core curriculum and didactics,
and ≥ 1 year of mentored research to foster careers
in genetics and genomics of lung diseases.
Through this program, NHLBI will provide
awards to organizations that include domestic, 
for-proﬁt and nonproﬁt, public and private institu-
tions, such as universities, colleges, and hospitals,
in order to develop a core curriculum and a didac-
tic component, and provide the participating
researchers with an opportunity to conduct a men-
tored research project. With this award, scholars
should develop the skills, knowledge, and experi-
ence to pursue additional grants (e.g., K08, K23,
R01), and to become independent investigators
and leaders in academic research programs in
genetics and genomics of lung diseases. Under the
current policy, recipients of K12 support may sub-
sequently apply for NHLBI-supported individual
mentored K-series awards (K01, K08, K23) pro-
vided that they had > 3 years of K12 support by
the time the individual K-series award is issued.
The combined total of K12 support plus individual
mentored K-series support must not exceed 6
years. Therefore, if an investigator has been sup-
ported by a K12 for 3 years, he/she will be able to
receive > 3 years of mentored individual career
award (K01, K08, K23, etc.).
Programs should emphasize the multifaceted
nature of the required career development program
which includes training.
The program director (PD) should draw on
the strengths of his/her institution, its faculty, and
resources to develop a specialized core curriculum
in genetics and genomics of lung diseases. The pro-
gram director, as the scientific and administrative
leader of the program, should obtain guidance
from a multidisciplinary advisory committee
responsible for program oversight and evaluation.
Faculty with expertise in multiple specialties
should serve as mentors. They should be responsi-
ble for: 1) supervising and evaluating scholars’
research skills development and educational activi-
ties; 2) identifying gaps in scholars’ knowledge and
skills and formulating plans to fill those gaps;
3) assuring that scholars design and implement a
short-term research project that will generate pub-
lishable results and preliminary data for a subse-
quent K08, K23, R01, and/or similar grant
application(s); and 4) developing, updating,
enhancing, evaluating, and revising curricula and
innovative teaching methods and tools.
The core curriculum for the first year should
provide: 1) a broad base knowledge of theories,
quantitative methods, applications of biotechnol-
ogy and bioinformatics pertinent to genome analy-
sis; and 2) an introduction to the associated social
and ethical implications of development in
biotechnology and genomics.
Didactics and hands-on activities in genetics
and genomics should expose scholars to: 1) experi-
ence in automatic DNA sequencing; 2) high-
throughput enzyme assays; 3) high-throughput
gene amplification; 4) bioinformatics analyses;
5) DNA microarray construction and analysis;
6) biostatistics; 7) observational and experimental
research designs and methods; 8) hypothesis devel-
opment; 9) responsible conduct of research, and
research ethics with human subjects; and 10) pre-
sentation and publication of research results.
Scholars entering the program should have
completed their M.D. or Ph.D degree within the
past 5 years and be interested in applying genetic
and genomic techniques to lung diseases. Some
individuals may not need to participate in the
entire core curriculum or didactics. These scholars
may elect additional career development and train-
ing in areas of interest, such as bioinformatics,
pharmaco-genomics, epidemiologic methods,
advanced biostatistics, and proteomics. Applicants
are encouraged to submit plans to accommodate
these potential scholars and to individualize their
career development and training experiences.
Late in year 1 and early in year 2, scholars,
with guidance and input from both mentors,
should design a research project that can be imple-
mented and the data analyzed in the remaining
period of support. Applications that focus mainly
on lung cancer will not be considered responsive to
this RFA.
The applicant institution and afﬁliated organi-
zations should: 1) have (involved) personnel with
the necessary expertise and experience in the con-
duct of genetics and genomics research; 2) have a
strong program of research on pulmonary diseases;
3) have facilities for genomic research; and
4) assure protected time for the program director,
mentors, and scholars.
This funding opportunity will use the NIH
Institutional Mentored Research Scientist
Development Program (K12) grant award mecha-
nism. As an applicant, you will be solely responsi-
ble for planning, directing, and executing the
proposed project.
This funding opportunity uses the just-in-time
budget concepts. It also uses the nonmodular bud-
get format described in the PHS 398 application
instructions (see http://grants.nih.gov/grants/fund-
ing/phs398/phs398.html). A detailed categorical
budget for the Initial Budget Period and the Entire
Proposed Period of Support is to be submitted
with the application.
The PHS 398 application instructions are
available at http://grants.nih.gov/grants/funding/
phs398/phs398.html in an interactive format.
Applicants must use the currently approved version
of the PHS 398. For further assistance, contact
GrantsInfo; 301-435-0714 (telecommunications
for the hearing impaired: TTY 301-451-0088), or
by e-mail: GrantsInfo@nih.gov.
Applications must be prepared using the most
current PHS 398 research grant application
instructions and forms. Applications must have a
D&B Data Universal Numbering System (DUNS)
number as the universal identifier when applying
for federal grants or cooperative agreements. The
D&B number can be obtained by calling 866-705-
5711 or through the web site at http://www.
dnb.com/us/. The D&B number should be entered
on line 11 of the face page of the PHS 398 form.
The letter of intent receipt date for this RFA is
30 October 2006, with the application receipt date
30 November 2006. The complete version of this
RFA is available at http://grants.nih.gov/grants/
guide/rfa-ﬁles/RFA-HL-07-004.html.
Contact: Sandra Colombini Hatch, Lung
Biology and Disease Program, Division of Lung
Diseases, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Rockledge ll Suite
10124, MSC 7952, Bethesda, MD 20892-7952
USA (for U.S. Postal Service express or regular mail)
Bethesda, MD 20817 USA (for express/courier
delivery; non-USPS service), 301-435-0222, fax:
301480-3557, e-mail: hatchs@nhlbi.nih.gov.
Reference RFA-HL-07-004.
Robert Wood Johnson Foundation Invites
Disparities Research Proposals
The Robert Wood Johnson Foundation (RWJF)
seeks to reduce racial and ethnic disparities in the
care of patients with cardiovascular disease, diabetes
mellitus type 2, and/or depression. To that end,
RWJF invites research proposals that offer solutions
towards reducing health care disparities. 
RWJF encourages researchers to include data
and analyses in their proposals to help better
understand these disparities related to: 1) subethnic
and other marginalized groups (e.g., Mexican,
Puerto Rican, Vietnamese, and American Indian);
and 2) acculturation factors (e.g., generation, years
in United States, age of migration, and language
proﬁciency). 
They will consider projects of up to $75,000
with a 1-year time frame that address one or more
of five key issues: 1) What is known about the
quality of care provided by the hospitals, physi-
cians, and community clinics that deliver the
majority of care to diverse patient populations?
2) Is health information technology (HIT) a
promising intervention for  reducing racial and
ethnic disparities in health care? 3) What differ-
ences in quality of care exist for Hispanic/Latino
subethnic groups (including Puerto Rican,
Mexican, Central or South American, and others)
and Asian subethnic groups (including Filipino,
Vietnamese, Cambodian, Chinese, and others)?
We are also interested in studies that focus on
American Indians, Alaska Natives, Native
Hawaiians and subgroups within the black or
African-American population (Caribbean, African,
West Indian, or other islander. 4) While some
researchers continue to document disparities in
care, others have found decreased, declining or a
complete absence of racial and ethnic disparities in
some types of quality of care indicators. How do
these ﬁndings ﬁt into the context of the wider dis-
parities literature? 5) How does patient-centered
care relate to better clinical outcomes?
Investigators must have at least 5 years of post-
doctoral research experience. These projects are not
intended for doctoral students or recent graduates. 
When submitting a brief proposal, please be
sure to include the phrase "Disparities research
questions" in the project title. 
For more information, visit these websites:
http://www.rwjf.org/global/email.jsp?id=677;
http://www.rwjf.org/portfolios/features/
featuredetail.jsp?featureID=1586=3=133; http://
www.rwjf.org/portfolios/features/featuredetail.jsp?
featureID=1586&type=3&iaid=133 or by e-mail:
disparitiesresearch@rwjf.org.